Literature DB >> 8201230

Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies.

M Rubio1, L Palau, J R Vivas, E del Potro, J Diaz-Mediavilla, A Alvarez, R Martinez, J J Picazo.   

Abstract

OBJECTIVE: To ascertain the etiology and outcome of episodes of bacteremia and fungemia over a three-year period (1990-1992) in patients with hematological malignancies.
DESIGN: Retrospective study.
SETTING: Hematology service of a 1,500-bed Spanish university hospital.
RESULTS: Of a total of 178 episodes of significant bacteremia or fungemia in 101 patients, 53% affected patients with acute leukemia. Gram-positive microorganisms were found to be the cause in 70% of the monomicrobial episodes. The most frequently isolated microorganism was coagulase-negative Staphylococcus (35%), followed by Staphylococcus aureus (11%). Most blood-stream infections occurred during an episode of neutropenia (59%). A total of 34 patients died during hospitalization; in 14, infection was the cause of death.
CONCLUSIONS: A marked increase in the incidence of bacteremias caused by gram-positive microorganisms has been observed in our hospital over the last 10 years, especially in patients with hematological malignancies. The mortality due to bacteremia is similar to that found by other authors in series of bacteremia in hematological patients, and we have not found significant differences in the mortality due to bacteremia between neutropenic and non-neutropenic patients (Infect Control Hosp Epidemiol 1994;15:101-104).

Entities:  

Mesh:

Year:  1994        PMID: 8201230     DOI: 10.1086/646869

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  15 in total

1.  Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients.

Authors:  D Yamamura; R Gucalp; P Carlisle; M Cimino; J Roberts; C Rotstein
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

Review 2.  A survey of the use of teicoplanin in patients with haematological malignancies and solid tumours.

Authors:  J M Davies
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 3.553

3.  Patterns and outcome of septicemia in neutropenic children with cancer in a Greek hospital.

Authors:  E Roilides; V Sidi; N Gompakis; M Tsivitanidou; A Katsaveli; D Koliouskas
Journal:  Infection       Date:  1998 May-Jun       Impact factor: 3.553

4.  Infections in acute leukemia: an analysis of 240 febrile episodes.

Authors:  R Jagarlamudi; L Kumar; V Kochupillai; A Kapil; U Banerjee; S Thulkar
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

5.  Role of bronchoalveolar lavage in immunocompromised patients with pneumonia treated with a broad spectrum antibiotic and antifungal regimen.

Authors:  I A Hohenadel; M Kiworr; R Genitsariotis; D Zeidler; J Lorenz
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

Review 6.  Coagulase-negative staphylococci.

Authors:  Karsten Becker; Christine Heilmann; Georg Peters
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

7.  Infections in acute myeloid leukemia: an analysis of 382 febrile episodes.

Authors:  Ajay Gupta; Mansher Singh; Harkirat Singh; Lalit Kumar; Atul Sharma; Sameer Bakhshi; Vinod Raina; Sanjay Thulkar
Journal:  Med Oncol       Date:  2009-10-15       Impact factor: 3.064

8.  A study of bacteremia in febrile neutropenic patients at a tertiary-care hospital with special reference to anaerobes.

Authors:  P Mathur; R Chaudhry; L Kumar; A Kapil; B Dhawan
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

9.  Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters.

Authors:  I Raad; R Hachem; H Hanna; P Bahna; I Chatzinikolaou; X Fang; Y Jiang; R F Chemaly; K Rolston
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-08       Impact factor: 3.267

10.  Causes of fever in cancer patients (prospective study over 477 episodes).

Authors:  E Toussaint; E Bahel-Ball; M Vekemans; A Georgala; L Al-Hakak; M Paesmans; M Aoun
Journal:  Support Care Cancer       Date:  2006-03-10       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.